Market Access

At Garnet Global Consultants LLP, we perform research and advocacy work to support pharmaceutical companies and pharma consulting firms. We help bring new medical products and technologies, including equipment, drugs, and software solutions, to the market, mainly in public reimbursement programs. 

For Sathguru Management Consultants (SMC) and its client, Global Antibiotic Research and Development Partnership (GARDP), provided technical support in price sensitivity and COGS analysis for Cefiderocol in India. Towards this, we provided support in primary research with public health stakeholders[1]to understand the level of adoption of high-end antibiotics, the accessibility of the Ceftaz-avi drug (generics vs. originator) across public hospitals, procurement and pricing details, and the optimal price range suggested for the new drug cefiderocol.

For SMC and its client, GARDP, developed a pricing strategy and roadmap for expanding the adoption/coverage of a novel antibiotic in the Indian public health system.

For Alivecor India, we introduced the KardiaMobile 6Lin as a sub-channel partner in the public health system: an innovative 6 lead compact, portable, and easy-to-use USFDA-approved ECG device. Implementation sites are PHCs and CHCs in Odisha, a central government hospital in Delhi, and a district facility in Durg (Chhattisgarh).

[1] Clinicians engaged in critical care from public hospitals; Medical Superintendents of Public Medical Colleges; Procurement/administrative stakeholders from public hospitals; Procurement teams in Central / State Government schemes; and Payors.